Es gab 50 kürzliche Insider-Transaktionen für InspireMD, Inc. (NSPR), darunter 32 Käufe und 14 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $2.3M und die gesamten Insider-Verkäufe auf $389.69K.
Bedeutende Insider mit kürzlicher Aktivität umfassen Gleason Shane Thomas, Roubin Gary S, Ward Scott R.. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — NSPR
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2026-02-02 |
Gleason Shane Thomas |
Chief Commercial Officer |
Informierter Verkauf |
2,000 |
$1.60 |
$3.21K |
1,139,177 |
| 2026-01-30 |
Gleason Shane Thomas |
Chief Commercial Officer |
Informierter Verkauf |
2,900 |
$1.63 |
$4.73K |
1,141,177 |
| 2026-01-29 |
Gleason Shane Thomas |
Chief Commercial Officer |
Informierter Verkauf |
5,000 |
$1.65 |
$8.25K |
1,144,077 |
| 2026-01-28 |
Gleason Shane Thomas |
Chief Commercial Officer |
Informierter Verkauf |
12,395 |
$1.65 |
$20.46K |
1,149,077 |
| 2026-01-27 |
Gleason Shane Thomas |
Chief Commercial Officer |
Informierter Verkauf |
4,781 |
$1.66 |
$7.96K |
1,161,472 |
| 2026-01-22 |
Gleason Shane Thomas |
Chief Commercial Officer |
Informierter Verkauf |
8,411 |
$1.57 |
$13.24K |
1,166,253 |
| 2026-01-21 |
Gleason Shane Thomas |
Chief Commercial Officer |
Informierter Verkauf |
17,593 |
$1.62 |
$28.55K |
1,174,664 |
| 2026-01-20 |
Gleason Shane Thomas |
Chief Commercial Officer |
Informierter Verkauf |
2,955 |
$1.59 |
$4.71K |
1,192,257 |
| 2026-01-16 |
Gleason Shane Thomas |
Chief Commercial Officer |
Informierter Verkauf |
2,250 |
$1.61 |
$3.63K |
1,195,212 |
| 2026-01-15 |
Gleason Shane Thomas |
Chief Commercial Officer |
Informierter Verkauf |
2,909 |
$1.58 |
$4.59K |
1,197,462 |
| 2026-01-14 |
Roubin Gary S |
Director |
RSU-Zuteilung |
88,053 |
- |
- |
744,478 |
| 2026-01-14 |
Ward Scott R. |
Director |
RSU-Zuteilung |
88,053 |
- |
- |
147,846 |
| 2026-01-14 |
Berman Michael |
Director |
RSU-Zuteilung |
88,053 |
- |
- |
352,586 |
| 2026-01-14 |
Cohen Raymond W |
Director |
RSU-Zuteilung |
44,030 |
- |
- |
92,417 |
| 2026-01-14 |
Stuka Paul |
Director |
RSU-Zuteilung |
132,076 |
- |
- |
523,704 |
| 2026-01-14 |
Dearen Danny L. |
Director |
RSU-Zuteilung |
44,030 |
- |
- |
102,047 |
| 2026-01-14 |
Slosman Marvin |
CEO and President |
RSU-Zuteilung |
1,114,792 |
- |
- |
3,535,658 |
| 2026-01-14 |
Lawless Michael A |
Chief Financial Officer |
RSU-Zuteilung |
226,695 |
- |
- |
691,695 |
| 2026-01-14 |
Gleason Shane Thomas |
Chief Commercial Officer |
RSU-Zuteilung |
453,390 |
- |
- |
1,200,371 |
| 2026-01-14 |
Tommasoli Andrea |
Chief Operating Officer |
RSU-Zuteilung |
226,695 |
- |
- |
954,389 |
| 2025-12-30 |
Arnold Kathryn |
Director |
RSU-Zuteilung |
26,276 |
$1.89 |
$49.66K |
111,221 |
| 2025-12-09 |
Stuka Paul |
Director |
Informierter Kauf |
5,073 |
$1.81 |
$9.18K |
391,628 |
| 2025-12-05 |
Stuka Paul |
Director |
Informierter Kauf |
5,073 |
$1.86 |
$9.44K |
388,918 |
| 2025-12-04 |
Stuka Paul |
Director |
Informierter Kauf |
10,130 |
$1.85 |
$18.74K |
383,845 |
| 2025-11-12 |
Stuka Paul |
Director |
Informierter Kauf |
13,431 |
$1.62 |
$21.76K |
373,715 |
| 2025-10-07 |
Roubin Gary S |
Director |
RSU-Zuteilung |
48,000 |
- |
- |
656,425 |
| 2025-09-16 |
Dearen Danny L. |
Director |
Unbekannt |
28,206 |
$2.41 |
$67.98K |
- |
| 2025-09-15 |
Kester Thomas J |
Director |
RSU-Zuteilung |
19,041 |
$2.38 |
$45.32K |
19,041 |
| 2025-07-31 |
Cohen Raymond W |
Director |
Unbekannt |
23,330 |
$2.79 |
$65.09K |
- |
| 2025-07-30 |
Roubin Gary S |
Director |
Informierter Kauf |
41,322 |
$2.42 |
$100K |
608,425 |
| 2025-07-30 |
Kester Thomas J |
Director |
Informierter Kauf |
30,991 |
$2.42 |
$75K |
420,758 |
| 2025-07-30 |
Stuka Paul |
Director |
Informierter Kauf |
20,661 |
$2.42 |
$50K |
444,195 |
| 2025-07-30 |
Slosman Marvin |
CEO and President |
Informierter Kauf |
10,330 |
$2.42 |
$25K |
2,420,866 |
| 2025-07-11 |
Kester Thomas J |
Director |
Optionsausübung (ITM) |
30,624 |
$1.38 |
$42.34K |
- |
| 2025-07-01 |
Stuka Paul |
Director |
Optionsausübung (ITM) |
87,500 |
$1.38 |
$120.99K |
- |
| 2025-06-29 |
Berman Michael |
Director |
Optionsausübung (ITM) |
61,248 |
$1.38 |
$84.69K |
- |
| 2025-06-25 |
Lawless Michael A |
Chief Financial Officer |
Unbekannt |
212,000 |
$2.24 |
$474.88K |
- |
| 2025-06-25 |
Roubin Gary S |
Director |
Optionsausübung (ITM) |
30,624 |
$1.38 |
$42.34K |
- |
| 2025-01-07 |
Roubin Gary S |
Director |
RSU-Zuteilung |
14,836 |
$2.71 |
$40.21K |
91,743 |
| 2025-01-07 |
Ward Scott R. |
Director |
RSU-Zuteilung |
7,418 |
$2.71 |
$20.1K |
24,065 |
| 2025-01-07 |
Berman Michael |
Director |
RSU-Zuteilung |
14,836 |
$2.71 |
$40.21K |
84,950 |
| 2025-01-07 |
Kester Thomas J |
Director |
RSU-Zuteilung |
14,836 |
$2.71 |
$40.21K |
84,947 |
| 2025-01-07 |
Shore Craig |
CFO and CAO |
RSU-Zuteilung |
106,218 |
$2.71 |
$287.85K |
417,706 |
| 2025-01-07 |
Stuka Paul |
Director |
RSU-Zuteilung |
22,254 |
$2.71 |
$60.31K |
128,129 |
| 2025-01-07 |
Verta Patrick |
EVP Clinical/medical Affairs |
RSU-Zuteilung |
37,933 |
$2.71 |
$102.8K |
117,281 |
| 2025-01-07 |
Slosman Marvin |
CEO and President |
RSU-Zuteilung |
254,985 |
$2.71 |
$691.01K |
937,796 |
| 2025-01-07 |
Arnold Kathryn |
Director |
RSU-Zuteilung |
14,836 |
$2.71 |
$40.21K |
84,945 |
| 2025-01-07 |
Gleason Shane Thomas |
Chief Commercial Officer |
RSU-Zuteilung |
106,218 |
$2.71 |
$287.85K |
289,346 |
| 2025-01-07 |
Tommasoli Andrea |
Chief Operating Officer |
RSU-Zuteilung |
106,218 |
$2.71 |
$287.85K |
282,917 |
| 2024-11-25 |
Ward Scott R. |
Director |
Unbekannt |
16,647 |
$2.94 |
$48.94K |
- |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
